小儿高脂血症的研究进展

来源 :中国医师杂志 | 被引量 : 0次 | 上传用户:ouwenliao
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
高脂血症实际上是血浆中某类或某几类脂蛋白水平升高的表现,严格说来应称为高脂蛋白血症,近年来已逐步认识到血浆中高密度脂蛋白-胆固醇(HDL-C)降低也是一种血脂紊乱,因此有人建议认为脂质异常血症能更准确全面反映血脂代谢紊乱。但是由于高脂血症这名称约定俗成,所以仍然广泛 In fact, hyperlipidemia is the performance of some or some types of lipoproteins in plasma, which should be strictly speaking referred to as hyperlipoproteinemia. In recent years, it has gradually realized that plasma high-density lipoprotein-cholesterol (HDL -C) reduction is also a dyslipidemia, it was suggested that lipid abnormalities can more accurately and accurately reflect the lipid metabolism disorders. However, the term hyperlipidemia is still common because of its convention
其他文献
任何神经病变或损害引起膀胱和括约肌功能障碍称之为神经源性膀胱括约肌功能障碍(neuropathic bladder-sphincter dysfunction NBSD).小儿NBSD发病率很高,仅脊髓脊膜膨出(MMC)发病率为1‰~2‰,5岁前MMC患儿病死率高达14%,主要死因为肾功能衰竭[1,2].最近小儿尿动力学检查技术进步以及小儿下尿路功能障碍术语标准化使得可以更加准确评估小儿神经源性膀